<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00534287</url>
  </required_header>
  <id_info>
    <org_study_id>EudraCT 2006-006984-21</org_study_id>
    <secondary_id>bmbf grant: 01 KI 01 06</secondary_id>
    <nct_id>NCT00534287</nct_id>
  </id_info>
  <brief_title>Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock</brief_title>
  <acronym>MaxSep</acronym>
  <official_title>Prospective, Randomized, Open, Multicentre Study About the Effect of an Empirical Antibiotic Monotherapy With Meropenem (Meronem®) Versus a Combination Therapy With Moxifloxacin (Avalox®) on Organ Dysfunction in Patients With Severe Sepsis and Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kompetenznetz Sepsis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kompetenznetz Sepsis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe sepsis and septic shock are diseases of infectious origin with a high risk of death.
      Antibiotic therapy is mandatory but it is unknown whether one antibiotic alone is sufficient
      for initial therapy. The purpose of this study is to compare a therapy with meropenem alone
      or the combination of meropenem plus moxifloxacin in the treatment of severe sepsis/ septic
      shock. Patients randomly receive one of the two treatments for at least 7 days but not longer
      than 14 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early intravenous empiric broad-spectrum antimicrobial therapy is an essential part of sepsis
      therapy. Inadequacy of empirical antibiotic therapy is associated with an increased mortality
      rate. Carbapenems are designed for empirical antimicrobial monotherapy. Combination therapy
      has been suggested but efficiency remains to be proven. In this study, antimicrobial
      monotherapy with meropenem is compared with a combination therapy of meropenem and
      moxifloxacin. It is hypothesized that the superior antibiotic therapy is associated with a
      lower overall organ dysfunction in sepsis. Study therapy lasts for at least 7 days unless
      microbiological results suggest otherwise. Study therapy may be extended to 14 days. Follow
      up examinations occur at 28 and 90 days. This investigator initiated study is supported by
      the German government (bmbf) and unrestricted industrial grants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean total SOFA score</measure>
    <time_frame>study duration but not longer than 14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 and 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response to therapy</measure>
    <time_frame>day 7 and day 10</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and microbiological cure</measure>
    <time_frame>End of study therapy (day 7-14) and release from ICU (max. day 21)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of adverse events (AEs, SAEs, SUSARs)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator free days</measure>
    <time_frame>28 and 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days without renal replacement therapy</measure>
    <time_frame>28 and 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor free days</measure>
    <time_frame>28 and 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA-subscores</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotics free days</measure>
    <time_frame>28 and 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs of antibiotic therapy</measure>
    <time_frame>ICU stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of resistances to antibiotics</measure>
    <time_frame>ICU stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of new infections</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>MeroMono</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Monotherapy with meropenem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MeroMoxi</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combination therapy with meropenem + moxifloxacin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>meropenem</intervention_name>
    <description>Empirical antibiotic therapy with 3 x 1 g intravenous meropenem. Dosage is adjusted in case of renal dysfunction. Recommended duration of therapy is 7 days but can be extended up to 14 days.</description>
    <arm_group_label>MeroMono</arm_group_label>
    <other_name>Meronem® (meropenem)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>meropenem, moxifloxacin</intervention_name>
    <description>Empirical antibiotic therapy with 3 x 1 g intravenous meropenem plus 1 x 400 mg intravenous moxifloxacin. Dosage of meropenem is adjusted in case of renal dysfunction. Recommended duration of therapy is 7 days but can be extended up to 14 days.</description>
    <arm_group_label>MeroMoxi</arm_group_label>
    <other_name>Meronem® (meropenem)</other_name>
    <other_name>Avalox® (moxifloxacin)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis or septic shock according to ACCP/SCCM criteria

          -  Onset of severe sepsis or septic shock &lt;24 h

          -  Informed consent

          -  Effective contraception in fertile women

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Pregnancy

          -  Breast-feeding women

          -  Pretreatment with meropenem, imipenem, or ertapenem within the last 4 weeks (&gt;1 daily
             dosage)

          -  Pretreatment with moxifloxacin,ciprofloxacin, or levofloxacin within the last 4 weeks
             (&gt;1 daily dosage)

          -  Pretreatment with a pseudomonas effective cephalosporin (cefepime, ceftazidim,
             cefpirom) or piperacillin within the last 48 hours (&gt;1 daily dosage).

          -  Pretreatment with other chinolones within the last 4 weeks (&gt;1 daily dosage)

          -  Presence of infection where guidelines recommend another antimicrobial therapy than
             the study medication (i.e. endocarditis)

          -  Evidence or strong clinical suspicion of a microorganism where the study medication is
             known to be ineffective (i.e. tuberculosis, MRSA- or VRE-infection)

          -  Known allergy against meropenem or moxifloxacin

          -  Tendon disease or injury due to past quinolone therapy

          -  Congenital or acquired prolongation of QT-interval

          -  Concomitant medication which prolongs the QT-interval

          -  Electrolyte imbalance, especially uncorrected hypokalemia

          -  Clinically relevant bradycardia

          -  Clinically relevant cardiac dysfunction with reduced left-ventricular ejection
             fraction

          -  Symptomatic arrhythmias in the medical history

          -  Significant hepatic impairment (Child-Pugh C) or elevation of liver enzymes &gt;5x the
             upper normal range

          -  No commitment to full patient support (i.e. DNR order)

          -  Patient's death is considered imminent due to coexisting disease

          -  Concomitant participation in another study or study participation with in the last 30
             days.

          -  Relationship of the patient to study team member (i.e. colleague, relative)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konrad Reinhart, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Jena; Dep. of Anesthesiology and Intensive Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Löffler, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Leipzig; Koordinierungszentrum für Klinische Studien Leipzig (KKSL)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Deufel, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hopitel Jena, Institute for Medical Chemistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aachen - Dep. of Anesthesiology</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Berlin - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Berlin - Dep. of Medicine (Cardiology, Angiology, Pneumology)</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Campus Mitte -Dep.of Infectiology and Pneumonology</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Campus Benjamin Franklin - Dep. of Medicine IV</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Neukölln - Cardiology</name>
      <address>
        <city>Berlin</city>
        <zip>12313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Neukölln - Dep. of Anesthesiology, Intensive Care Medicine and Pain Therapy</name>
      <address>
        <city>Berlin</city>
        <zip>12313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Berlin - Campus Virchow-Klinikum - Dep. of Nephrology</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ev. Krankenhaus Gilead I - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Bielefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Bonn - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Brandenburg - Intensive Care Unit</name>
      <address>
        <city>Brandenburg</city>
        <zip>14770</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Darmstadt - Dep. of Anesthesiology, Intensive Care Medicine and Pain Therapy</name>
      <address>
        <city>Darmstadt</city>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dessau - Dep. of Medicine</name>
      <address>
        <city>Dessau</city>
        <zip>06847</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Lippe-Detmold - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Detmold</city>
        <zip>32756</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Dresden - Dep. of Anesthesiology and Intensive Care Med.</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Erfurt - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Erlangen-Nürnberg - Dep. of Medicine IV</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Freiburg - Dep. of Medicine III</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ernst-Moritz-Arndt-Universität Greifswald - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ernst-Moritz-Arndt-Universität Greifswald, Dep. of Internal Medicine B</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik am Eichert - Dep. of Anesthesiology, Intensive Care Medicine, and Pain Therapy</name>
      <address>
        <city>Göppingen</city>
        <zip>73035</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georg August Universität Göttingen - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin-Luther-Universität Halle-Wittenberg - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Halle</city>
        <zip>06097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Martha-Maria Halle-Dölau gGmbH - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf - Dep. of Intensive Care Medicine</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Hannover Nordstadt - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Hannover</city>
        <zip>30167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Dep. of Internal Medicine/ Pneumology</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg - Dep. of Medicine IV</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg - Dep. of Visceral and Transplantation Surgery</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westküstenklinikum Heide - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Heide</city>
        <zip>25746</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Saarland - Deop. of Anesthesiology, Intensive Care Medicine, and Pain Therapy</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Jena, Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Jena</city>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Kiel - Dep. of. Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Köln - Dep. of Internal Medicine I</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Merheim - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Köln</city>
        <zip>51109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Leipzig - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ludwigshafen am Rhein - Dep. of Cardiac Surgery</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Lüdenscheid - Dep. of Anesthesiology</name>
      <address>
        <city>Luedenscheid</city>
        <zip>58515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Mannheim - Dep. of Medicine I</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Munich - Dep. of Internal Medicine</name>
      <address>
        <city>Munich</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Munich Harlaching - Dep. of Internal Acute Medicine and Prevention</name>
      <address>
        <city>Munich</city>
        <zip>81545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar - Dep. of Anesthesiology</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Münster - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg - Dep. of Anesthesiology, Intensive Care Medicine, Emergency Medicine, Pain Therapy</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ernst von Bergmann - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Rostock - Dep. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ev. Jung-Stilling-Krankenhaus - Dep. of Anesthesiology, Intensive Care Medicine, Emergency Medicine</name>
      <address>
        <city>Siegen</city>
        <zip>57074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Tübingen - Dep. of Medicine</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ulm - Dep. of Internal Medicine II</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stiftung Juliusspital Würzburg - Dep. of Medicine (Cardiology)</name>
      <address>
        <city>Würzburg</city>
        <zip>97070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.sepsis-gesellschaft.de/DSG/Deutsch/SepNet?sid=nbGlH39rI6b9u2fBVVhxiM&amp;iid=1</url>
    <description>Competence Network Sepsis (SepNet)</description>
  </link>
  <link>
    <url>http://www.sepsis-gesellschaft.de/</url>
    <description>German Sepsis Society</description>
  </link>
  <reference>
    <citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992 Jun;20(6):864-74. Review.</citation>
    <PMID>1597042</PMID>
  </reference>
  <reference>
    <citation>Reinhart K, Brunkhorst F, Bone H, Gerlach H, Gründling M, Kreymann G, Kujath P, Marggraf G, Mayer K, Meier-Hellmann A, Peckelsen C, Putensen C, Quintel M, Ragaller M, Rossaint R, Stüber F, Weiler N, Welte T, Werdan K; Deutsche Sepsis-Gesellschaft e.V. [Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine]. Anaesthesist. 2006 Jun;55 Suppl 1:43-56. Review. German.</citation>
    <PMID>17051663</PMID>
  </reference>
  <reference>
    <citation>Bochud PY, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004 Nov;32(11 Suppl):S495-512. Review.</citation>
    <PMID>15542958</PMID>
  </reference>
  <reference>
    <citation>Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003 Nov;115(7):529-35.</citation>
    <PMID>14599631</PMID>
  </reference>
  <reference>
    <citation>Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 2004 Aug;4(8):519-27.</citation>
    <PMID>15288826</PMID>
  </reference>
  <reference>
    <citation>Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007 Apr;33(4):606-18. Epub 2007 Feb 24.</citation>
    <PMID>17323051</PMID>
  </reference>
  <reference>
    <citation>Pletz MW, Bloos F, Burkhardt O, Brunkhorst FM, Bode-Böger SM, Martens-Lobenhoffer J, Greer MW, Stass H, Welte T. Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock. Intensive Care Med. 2010 Jun;36(6):979-83. doi: 10.1007/s00134-010-1864-y. Epub 2010 Mar 25.</citation>
    <PMID>20336279</PMID>
  </reference>
  <results_reference>
    <citation>Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, Jaschinski U, Meier-Hellmann A, Weyland A, Gründling M, Moerer O, Riessen R, Seibel A, Ragaller M, Büchler MW, John S, Bach F, Spies C, Reill L, Fritz H, Kiehntopf M, Kuhnt E, Bogatsch H, Engel C, Loeffler M, Kollef MH, Reinhart K, Welte T; German Study Group Competence Network Sepsis (SepNet). Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA. 2012 Jun 13;307(22):2390-9. doi: 10.1001/jama.2012.5833.</citation>
    <PMID>22692171</PMID>
  </results_reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2007</study_first_submitted>
  <study_first_submitted_qc>September 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2007</study_first_posted>
  <last_update_submitted>June 28, 2012</last_update_submitted>
  <last_update_submitted_qc>June 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>antibiotics</keyword>
  <keyword>carbapenems</keyword>
  <keyword>fluoroquinolones</keyword>
  <keyword>Severe sepsis and septic shock</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
    <mesh_term>Meropenem</mesh_term>
    <mesh_term>Thienamycins</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

